Robot for removing cancer cells

Abstract

The invention discloses a robot for removing cancer cells, which comprises a main engine and an operating table; the middle of the front face of an operation main engine is fixed with an operating table; above the front face of the main engine is fixed with a display device; above one side of the main engine is fixed with a robotic arm; a support is fixed on one side of the robotic arm away from the main engine; a needle is fixed on one side of the support far from the robotic arm; a cavity body is formed in the inner part of the support; an electric motor is fixed above the middle side of theinner part of the cavity body. According to the robot for removing cancer cells, the tumor is treated in the early stage, thereby placing a dissecting device near the cancer cells inside the blood vessel by interventional means, avoiding the risk of massive bleeding caused by aortic vascular incision, and greatly reducing the risk of surgery; at the same time, through a 3D vision device, it is convenient for medical personnel to determine the location of the cancer cells; through an ion thinner, the cancer cells are stripped into the internal vacuum ion thinner, so that cancer cells die naturally.

Description

technical field [0001] The invention relates to the technical field of robots, in particular to a cancer cell stripping robot. Background technique [0002] Cancer tumors can thrive in blood vessels. When colorectal cancer spreads, cancer cells will express a gene called PRL-3 in large quantities. Researchers from the Institute of Molecular and Cellular Biology (IMCB) Dr. Zeng Qi and Guo After conducting experiments on white mice, Dr. Ke found that the PRL-3 gene can cause cancer cells to "settle down" in blood vessels, form cancerous tumors, erode blood vessel walls, or integrate with blood vessels. Cell proliferation drugs, although anti-cell proliferation drugs can kill tumor cells, due to the support of peripheral blood vessels, residual tumor cells can still obtain blood supply and continue to grow. At the same time, abnormal tumor blood vessels reduce the delivery of drugs to the tumor tissue. Ultimately, the curative effect of anti-cell proliferation therapy is limit...

AI Technical Summary

Problems solved by technology

[0002] Cancer tumors can flourish in blood vessels. When colorectal cancer spreads, cancer cells will express a gene called PRL-3 in large quantities. Researchers from the Institute of Molecular and Cellular Biology (IMCB) Dr. Zeng Qi and Guo After conducting experiments on white mice, Dr. Ke found that the PRL-3 gene can cause cancer cells to "settle down" in blood vessels, form cancerous tumors, erode blood vessel walls, or integrate with blood vessels. Cell proliferation drugs, although anti-cell proliferation drugs can kill tumor cells, due to the support of peripheral blood vessels, residual tumor cells can still obtain blood supply and continue to grow. At the same time, abnormal tumor blood vessels reduce the delivery of drugs to the tumor tissue. Ultimately, the curative effect of anti-cell proliferation therapy is limited, and surgical treatment can only dissect the blocked blood vessels, and the aorta will have the risk of massive bleeding during the dissection operation, which greatly increases the risk of surgery. The medical staff cannot accurately determine the location of the cancer cells, which will cause the cancer cells to be ignored and incomplete, and the disease will recur, which will increase the difficulty of the operation

Images